Targeted Therapies in Lung Cancer Video Perspectives

Balazs Halmos, MD, director of thoracic oncology and clinical cancer genomics at Montefiore Medical Center and professor of medicine at the Albert Einstein College of Medicine, spoke with Healio about molecular testing for oncogenic drivers, targeted therapy in practice and the progression of precision medicine in lung cancer care.

In these videos, Halmos discussed:

• The ‘dramatic’ evolution of precision medicine in lung cancer treatment, highlighting the increase in actionable targets;
• Developments in molecular testing;
• Targeted therapy treatment options for different oncogenic drivers, and which targets are actionable in practice;
• FDA approvals of targeted therapies over the past few years; and
• Important areas of focus for future research, including integrating treatments into the early-stage setting.